Corcept Therapeutics
CORT
CORT
243 hedge funds and large institutions have $1.65B invested in Corcept Therapeutics in 2022 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 97 increasing their positions, 72 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
26% less capital invested
Capital invested by funds: $2.24B → $1.65B (-$586M)
73% less call options, than puts
Call options by funds: $3.53M | Put options by funds: $13M
Holders
243
Holding in Top 10
3
Calls
$3.53M
Puts
$13M
Top Buyers
| 1 | +$11.2M | |
| 2 | +$9.91M | |
| 3 | +$3.26M | |
| 4 |
Pacer Advisors
Malvern,
Pennsylvania
|
+$3.02M |
| 5 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
+$2.88M |
Top Sellers
| 1 | -$46.3M | |
| 2 | -$28.6M | |
| 3 | -$25.4M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
-$14.5M |
| 5 |
D.E. Shaw & Co
New York
|
-$8.52M |